Consensus document on diagnostic and prognostic criteria for transplant-associated thrombotic microangiopathy (TA TMA).
Evidence-based clinical decision support from UpToDate on the treatment of GVHD.
A position statement by GVHD experts from the European Society for Blood and Marrow Transplantation (EBMT), the National Institutes of Health (NIH), and the Center for International Blood and Marrow Transplant Research (CIBMTR) that reviews guidelines for GVHD and addresses questions in treating it.
Resources, answers, and support for patients on GVHD, all steps of the transplant journey, as well as opportunities to connect with online groups, mentor services, and fellow patients.
A fact sheet from the Leukemia & Lymphoma Society for patients on understanding and managing GVHD.
An FAQ from the American Society for Transplantation and Cellular Therapy (ASTCT) on the prevention and management of acute and chronic GVHD following cord blood transplantation based on available guidelines.
Guideline from the National Comprehensive Cancer Network (NCCN) on hematopoietic cell transplantation that includes guidance on managing GVHD.
A network of medical experts, transplant and cellular therapy survivors, and family caregivers help patients and families navigate the transplant and cellular therapy experience.